救命救急診療の世界市場分析:テスト別(ルーチン・特殊化学、フローサイトメトリー、血液学、免疫タンパク質、微生物および感染症、凝固試験)、エンドユーザー別(手術室、緊急治療室、集中治療室)、地域別(米国、カナダ、ドイツ、英国、中国、インド、ブラジル、メキシコ、南アフリカ)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Critical Care Diagnostics Market Analysis By Test Type (Routine & Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Diseases, Coagulation Testing), By End-use type (Operation Rooms, Emergency Rooms, Intensive Care Units), By Region (U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa) And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1. Market segmentation
4.2. Market size and growth prospects, 2013 – 2024
4.3. Critical care diagnostics: Market dynamics
4.3.1. Market Driver Analysis
4.3.1.1. Growing patient demand for rapid diagnosis and treatment
4.3.1.2. Increasing geriatric population
4.3.1.3. Telehealth and remote communications between diagnostics and laboratories
4.3.2. Market Restraint Analysis
4.3.2.1. Increased cost of diagnostics tools and dearth of skilled labor
4.4. Penetration & growth prospect mapping
4.5. Critical Care Diagnostics Company – SWOT analysis, by factor (political &legal, economic and technological)
4.6. Industry Analysis – Porter’s
Chapter 5. Market Categorization 1: Type Estimates & Trend Analysis
5.1. Critical care diagnostics market: Type movement analysis
5.1.1. Routine and special chemistry
5.1.1.1. Routine and special chemistry market estimates and forecasts, 2013 – 2024 (USD Million)
5.1.2. Flow cytometry
5.1.2.1. Flow cytometry market estimates and forecasts, 2013 – 2024 (USD Million)
5.1.3. Hematology
5.1.3.1. Hematology market estimates and forecasts, 2013 – 2024 (USD Million)
5.1.4. Microbial and infectious test
5.1.4.1. Microbial and infectious test market estimates and forecasts, 2013 – 2024 (USD Million)
5.1.5. Coagulation
5.1.5.1. Coagulation market estimates and forecasts, 2013 – 2024 (USD Million)
5.1.6. Others
5.1.6.1. Other market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6. Market Categorization 2: End-User Estimates & Trend Analysis
6.1. Critical care diagnostics market: End-user movement analysis
6.1.1. Operating rooms
6.1.1.1. Operating rooms market estimates and forecasts, 2013 – 2024 (USD Million)
6.1.2. Emergency rooms
6.1.2.1. Emergency rooms market estimates and forecasts, 2013 – 2024 (USD Million)
6.1.3. Intensive care units
6.1.3.1. Intensive care units market estimates and forecasts, 2013 – 2024 (USD Million)
6.1.4. Others
6.1.4.1. Other market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 7. Market Categorization 3: Regional Estimates & Trend Analysis, by Type & End-User
7.1. Critical care diagnostics market share by region, 2016 & 2024
7.1.1. North America
7.1.1.1. U.S. market estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.1.2. U.S. market estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.1.3. Canada market estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.1.4. Canada market estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.2. Europe
7.1.2.1. Germany market estimates and forecasts by type, 2013 – 2024 (USD Million)
7.1.2.2. Germany market estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.2.3. UK market estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.2.4. UK market estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.3. Asia Pacific
7.1.3.1. China market estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.3.2. China market estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.3.3. India market estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.3.4. India market estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.4. Latin America
7.1.4.1. Mexico estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.4.2. Mexico estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.4.3. Brazil estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.4.4. Brazil estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
7.1.5. MEA
7.1.5.1. South Africa estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.5.2. South Africa estimates and forecasts, by end-user,2013 – 2024 (USD Million)
7.1.5.3. Saudi Arabia estimates and forecasts, by type, 2013 – 2024 (USD Million)
7.1.5.4. Saudi Arabia estimates and forecasts, by end-user, 2013 – 2024 (USD Million)
Chapter 8. Competitive Landscape
8.1. Strategy framework
8.2. Market participation categorization
8.3. Company Profiles
8.3.1. Abbott
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Alere, Inc.
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Beckman-Coulter/ Danaher
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Roche Diagnostics Ltd.
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Becton Dickinson & Co.
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. EKF Diagnostics
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. BioMerieux, Inc.
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Siemens Healthcare Diagnostics
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Chembio Diagnostic Systems, Inc.
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Bayer Healthcare AG
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:救命救急診療の世界市場分析:テスト別(ルーチン・特殊化学、フローサイトメトリー、血液学、免疫タンパク質、微生物および感染症、凝固試験)、エンドユーザー別(手術室、緊急治療室、集中治療室)、地域別(米国、カナダ、ドイツ、英国、中国、インド、ブラジル、メキシコ、南アフリカ)、セグメント予測
■ 英文:Critical Care Diagnostics Market Analysis By Test Type (Routine & Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Diseases, Coagulation Testing), By End-use type (Operation Rooms, Emergency Rooms, Intensive Care Units), By Region (U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa) And Segment Forecasts To 2024
■ 発行日:2016年8月10日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707228
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。